Novel drug combination nanoparticles exhibit enhanced plasma exposure and dose-responsive effects on eliminating breast cancer lung metastasis.
Early diagnosis along with new drugs targeted to cancer receptors and immunocheckpoints have improved breast cancer survival. However, full remission remains elusive for metastatic breast cancer due to dose-limiting toxicities of heavily used, highly potent drug combinations such as gemcitabine and...
Guardado en:
Autores principales: | Qingxin Mu, Jesse Yu, James I Griffin, Yan Wu, Linxi Zhu, Lisa A McConnachie, Rodney J Y Ho |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cb89d7d76ccd4535a410f364e5bbf9bc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Perifosine, a Bioavailable Alkylphospholipid Akt Inhibitor, Exhibits Antitumor Activity in Murine Models of Cancer Brain Metastasis Through Favorable Tumor Exposure
por: Keisuke Taniguchi, et al.
Publicado: (2021) -
Optimisation and Prediction of the Coagulant Dose for the Elimination of Organic Micropollutants Based on Turbidity
por: Hichem Tahraoui, et al.
Publicado: (2021) -
Plasma redox imbalance caused by albumin oxidation promotes lung-predominant NETosis and pulmonary cancer metastasis
por: Minoru Inoue, et al.
Publicado: (2018) -
Proton beam radiotherapy in the management of uveal melanoma: Clinical experience in Scotland
por: Samir Aziz, et al.
Publicado: (2008) -
Multiomics Landscape Uncovers the Molecular Mechanism of the Malignant Evolution of Lung Adenocarcinoma Cells to Chronic Low Dose Cadmium Exposure
por: Shun-Dong Dai, et al.
Publicado: (2021)